+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Phase 2
Age: 18Years +
All Genders
ID06102525

Phase 12a Study of RZ-001 and Valganciclovir Treatment for Glioblastoma Evaluating Safety, Tolerability, and Effectiveness in Adults

Led by Rznomics, Inc. · Updated on 2025-09-05

43

Participants Needed

6

Research Sites

8 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety, tolerability, immune response, and early clinical effects of a treatment combining RZ-001 with Valganciclovir VGCV in adults with hTERT-positive glioblastoma GBM, a type of grade 4 astrocytoma brain tumor. This Phase 12a, open-label study aims to find the best dose and understand how the treatment works in this patient group. The study is sponsored by Rznomics, Inc. and includes two parts dose escalation and dose expansion. The study has two parts Part 1 is a dose-escalation phase to find the maximum tolerated dose or recommended dose for Phase 2, where RZ-001 is given through injections directly into the tumor. Part 2 is the dose-expansion phase, which uses the optimal dose from Part 1 to further explore the treatments clinical effects. Participants receive one of several doses of RZ-001 combined with oral VGCV, a drug that works alongside RZ-001 to target tumor cells. Participants will be monitored closely from Day 1 to Day 28 for safety, side effects, laboratory changes, and survival. Researchers will assess immune response markers, tumor response, neurologic function, and progression-free survival using specialized scales and criteria. The study includes multiple evaluations such as adverse event tracking, lab tests, and assessments of overall health and tumor activity. Participants are followed until at least Day 15 for survival and tumor response measurements.

CONDITIONS

Brief Title

A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 With Valganciclovir (VGCV) in Subjects With Glioblastoma

Research Team

R

Rznomics Inc.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here